- Home
- RHI vs AAPG Comparison
RHI vs AAPG Comparison
Compare RHI & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RHI
- AAPG
- Stock Information
- Founded
- RHI 1948
- AAPG 2009
- Country
- RHI United States
- AAPG China
- Employees
- RHI N/A
- AAPG N/A
- Industry
- RHI Professional Services
- AAPG Biotechnology: Pharmaceutical Preparations
- Sector
- RHI Consumer Discretionary
- AAPG Health Care
- Exchange
- RHI Nasdaq
- AAPG Nasdaq
- Market Cap
- RHI 3.7B
- AAPG 4.0B
- IPO Year
- RHI N/A
- AAPG 2025
- Fundamental
- Price
- RHI $37.17
- AAPG $41.98
- Analyst Decision
- RHI Hold
- AAPG Buy
- Analyst Count
- RHI 5
- AAPG 1
- Target Price
- RHI $49.80
- AAPG N/A
- AVG Volume (30 Days)
- RHI 1.8M
- AAPG 9.5K
- Earning Date
- RHI 10-21-2025
- AAPG 08-20-2025
- Dividend Yield
- RHI 6.34%
- AAPG N/A
- EPS Growth
- RHI N/A
- AAPG N/A
- EPS
- RHI 1.75
- AAPG N/A
- Revenue
- RHI $5,569,026,000.00
- AAPG $54,524,554.00
- Revenue This Year
- RHI N/A
- AAPG N/A
- Revenue Next Year
- RHI $3.32
- AAPG $387.72
- P/E Ratio
- RHI $21.22
- AAPG N/A
- Revenue Growth
- RHI N/A
- AAPG N/A
- 52 Week Low
- RHI $33.18
- AAPG $16.50
- 52 Week High
- RHI $78.41
- AAPG $48.45
- Technical
- Relative Strength Index (RSI)
- RHI 46.46
- AAPG N/A
- Support Level
- RHI $36.07
- AAPG N/A
- Resistance Level
- RHI $37.22
- AAPG N/A
- Average True Range (ATR)
- RHI 1.09
- AAPG 0.00
- MACD
- RHI 0.32
- AAPG 0.00
- Stochastic Oscillator
- RHI 66.03
- AAPG 0.00
About RHI Robert Half Inc.
Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry. The firm generates annual revenue of around $7 billion.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.